Last quarter (Q ), Akso Health Group Sponsored ADR's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Akso Health Group Sponsored ADR's net income was $―. See Akso Health Group Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	-	$ 14.72M	$ 5.20M	$ 1.75M	$ 6.91M	$ 61.33M
Cost of Revenue	-	-	-	$ 544.57K	$ 1.03M	$ 7.40M
Gross Profit	-	-	-	$ 1.21M	$ 5.88M	$ 53.93M
Operating Expense	-	-	-	$ 28.36M	$ 22.30M	$ 48.84M
Operating Income	-	-	-	$ -27.15M	$ -16.42M	$ 5.10M
Net Non Operating Interest Income Expense	-	-	-	$ -2.15M	$ -2.50M	$ 0.00
Other Income Expense	-	-	-	$ -1.76M	$ -27.96M	$ 2.31M
Pretax Income	-	$ -13.07M	$ -4.01M	$ -31.07M	$ -46.87M	$ 7.41M
Tax Provision	-	$ 17.55K	$ 92.82K	$ 482.98K	$ 489.95K	$ 1.87M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	$ -1.36M	$ -16.85M	$ -34.83M	$ -71.20M	$ 5.53M
Basic EPS	-	$ -0.04	$ -0.56	$ -0.71	$ -4.38	$ 0.33
Diluted EPS	-	$ -0.04	$ -0.56	$ -0.71	$ -4.38	$ 0.30
Basic Average Shares	-	$ 68.60M	$ 59.61M	$ 48.84M	$ 16.25M	$ 16.23M
Diluted Average Shares	-	$ 68.60M	$ 59.61M	$ 48.84M	$ 16.25M	$ 17.64M
Dividend Per Share	-	-	-	$ 0.00	$ 0.00	$ 0.81
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	$ 0.75
Reported Normalized Diluted E P S	-	-	-	-	-	$ 0.66
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	-	-	-	$ 28.90M	$ 23.33M	$ 56.23M
Net Income From Continuing And Discontinued Operation	-	$ -1.36M	$ -16.85M	$ -34.83M	$ -71.20M	$ 5.53M
Normalized Income	-	$ -10.32M	-	$ -30.35M	$ -25.47M	$ 5.53M
Interest Expense	-	-	$ 804.14K	$ 2.15M	$ 2.50M	$ 0.00
EBIT	-	-	-	$ -28.91M	$ -44.37M	$ 7.41M
EBITDA	-	-	-	$ -28.90M	$ -44.25M	$ 7.81M

Currency in USD

Akso Health Group Sponsored ADR Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing